Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni G Camici

Showing results (81-90 of 179) with videos related to

Pageof 18
Sort By:
European Journal of Clinical Investigation|December 5, 2019
Apold1 deficiency associates with increased arterial thrombosis in vivoCandela Diaz-Cañestro, Nicole R Bonetti, Patricia Wüst, et al.
Haematologica|July 22, 2017
Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearanceSimona Stivala, Sara Gobbato, Laura Infanti, et al.
Haematologica|December 2, 2017
In response to the comment by Hechler <i>et al</i>.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearanceSimona Stivala, Sara Gobbato, Laura Infanti, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 13, 2016
Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's diseaseMario Merlini, Yi Shi, Stephan Keller, et al.
Circulation|September 27, 2006
Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stentsGiovanni G Camici, Jan Steffel, Alexander Akhmedov, et al.
European Heart Journal|December 17, 2013
PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent designErik W Holy, Philipp Jakob, Thomas Eickner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2011
Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activationErik W Holy, Marc Forestier, Eva K Richter, et al.
Cardiovascular Research|July 4, 2023
Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stressKangmin Yang, Srividya Velagapudi, Alexander Akhmedov, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2010
Aging induces endothelial dysfunction while sparing arterial thrombosisSimon F Stämpfli, Alexander Akhmedov, Cathérine Gebhard, et al.
European Journal of Clinical Investigation|March 22, 2022
Microvesicles released from activated CD4<sup>+</sup> T cells alter microvascular endothelial cell functionDaria Vdovenko, Carolina Balbi, Dario Di Silvestre, et al.
Pageof 18

Showing results (81-90 of 179) with videos related to

Sort By:
Pageof 18
European Journal of Clinical Investigation|December 5, 2019
Apold1 deficiency associates with increased arterial thrombosis in vivoCandela Diaz-Cañestro, Nicole R Bonetti, Patricia Wüst, et al.
Haematologica|July 22, 2017
Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearanceSimona Stivala, Sara Gobbato, Laura Infanti, et al.
Haematologica|December 2, 2017
In response to the comment by Hechler <i>et al</i>.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearanceSimona Stivala, Sara Gobbato, Laura Infanti, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 13, 2016
Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's diseaseMario Merlini, Yi Shi, Stephan Keller, et al.
Circulation|September 27, 2006
Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stentsGiovanni G Camici, Jan Steffel, Alexander Akhmedov, et al.
European Heart Journal|December 17, 2013
PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent designErik W Holy, Philipp Jakob, Thomas Eickner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2011
Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activationErik W Holy, Marc Forestier, Eva K Richter, et al.
Cardiovascular Research|July 4, 2023
Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stressKangmin Yang, Srividya Velagapudi, Alexander Akhmedov, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2010
Aging induces endothelial dysfunction while sparing arterial thrombosisSimon F Stämpfli, Alexander Akhmedov, Cathérine Gebhard, et al.
European Journal of Clinical Investigation|March 22, 2022
Microvesicles released from activated CD4<sup>+</sup> T cells alter microvascular endothelial cell functionDaria Vdovenko, Carolina Balbi, Dario Di Silvestre, et al.
Pageof 18